Can a Former Pfizer Executive Catalyze Nike’s Sluggish Turnaround?

Can a Former Pfizer Executive Catalyze Nike’s Sluggish Turnaround?  Barron's

Summary aggregated from Barron's's public RSS feed. The full reporting belongs to Barron's — please read it on their site.